Relay Therapeutics (RLAY) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $6.2 million.
- Relay Therapeutics' Other Non Operating Income fell 2446.76% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 million, marking a year-over-year decrease of 1447.83%. This contributed to the annual value of $34.8 million for FY2024, which is 1203.15% up from last year.
- Per Relay Therapeutics' latest filing, its Other Non Operating Income stood at $6.2 million for Q3 2025, which was down 2446.76% from $6.5 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Other Non Operating Income ranged from a high of $9.0 million in Q1 2024 and a low of $157000.0 during Q3 2021
- Over the past 5 years, Relay Therapeutics' median Other Non Operating Income value was $6.5 million (recorded in 2025), while the average stood at $5.0 million.
- As far as peak fluctuations go, Relay Therapeutics' Other Non Operating Income tumbled by 8180.9% in 2021, and later skyrocketed by 190299.63% in 2022.
- Relay Therapeutics' Other Non Operating Income (Quarter) stood at $267000.0 in 2021, then skyrocketed by 1903.0% to $5.3 million in 2022, then soared by 62.7% to $8.7 million in 2023, then rose by 3.15% to $9.0 million in 2024, then tumbled by 30.45% to $6.2 million in 2025.
- Its Other Non Operating Income was $6.2 million in Q3 2025, compared to $6.5 million in Q2 2025 and $7.8 million in Q1 2025.